David Shaw’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.57M | Buy |
92,990
+87,294
| +1,533% | +$5.12M | ﹤0.01% | 1847 |
|
|
2026
Q1 | $218K | Sell |
5,696
-56,069
| -91% | -$1.77M | ﹤0.01% | 4176 |
|
|
2025
Q4 | $1.35M | Sell |
61,765
-69,310
| -53% | -$1.44M | ﹤0.01% | 3345 |
|
|
2025
Q3 | $2.81M | Sell |
131,075
-101,313
| -44% | -$2.27M | ﹤0.01% | 2713 |
|
|
2025
Q2 | $5.96M | Sell |
232,388
-16,020
| -6% | -$469K | ﹤0.01% | 1893 |
|
|
2025
Q1 | $9.09M | Buy |
248,408
+40,983
| +20% | +$1.41M | 0.01% | 1468 |
|
|
2024
Q4 | $6.36M | Sell |
207,425
-68,431
| -25% | -$2.28M | ﹤0.01% | 1791 |
|
|
2024
Q3 | $10.4M | Buy |
275,856
+197,970
| +254% | +$7.63M | 0.01% | 1410 |
|
|
2024
Q2 | $3.08M | Buy |
77,886
+10,317
| +15% | +$334K | ﹤0.01% | 2243 |
|
|
2024
Q1 | $2.27M | Sell |
67,569
-11,614
| -15% | -$390K | ﹤0.01% | 2537 |
|
|
2023
Q4 | $2.64M | Buy |
79,183
+41,534
| +110% | +$1.34M | ﹤0.01% | 2454 |
|
|
2023
Q3 | $1.18M | Buy |
37,649
+20,864
| +124% | +$656K | ﹤0.01% | 2962 |
|
|
2023
Q2 | $532K | Buy |
16,785
+2,033
| +14% | +$65.7K | ﹤0.01% | 3400 |
|
|
2023
Q1 | $487K | Sell |
14,752
-5,728
| -28% | -$188K | ﹤0.01% | 3565 |
|
|
2022
Q4 | $659K | Buy |
20,480
+811
| +4% | +$27.6K | ﹤0.01% | 3707 |
|
|
2022
Q3 | $702K | Buy |
19,669
+10,043
| +104% | +$417K | ﹤0.01% | 3832 |
|
|
2022
Q2 | $395K | Sell |
9,626
-20,789
| -68% | -$1.01M | ﹤0.01% | 4231 |
|
|
2022
Q1 | $1.76M | Sell |
30,415
-33,884
| -53% | -$1.85M | ﹤0.01% | 3423 |
|
|
2021
Q4 | $3.78M | Sell |
64,299
-23,136
| -26% | -$1.4M | ﹤0.01% | 2693 |
|
|
2021
Q3 | $5.31M | Buy |
87,435
+699
| +0.8% | +$41K | ﹤0.01% | 2059 |
|
|
2021
Q2 | $5.2M | Buy |
86,736
+5,200
| +6% | +$261K | ﹤0.01% | 1998 |
|
|
2021
Q1 | $3.85M | Sell |
81,536
-16,444
| -17% | -$677K | ﹤0.01% | 2056 |
|
|
2020
Q4 | $3.68M | Sell |
97,980
-11,058
| -10% | -$364K | ﹤0.01% | 2106 |
|
|
2020
Q3 | $3.57M | Sell |
109,038
-25,058
| -19% | -$1.06M | ﹤0.01% | 1945 |
|
|
2020
Q2 | $6.08M | Buy |
134,096
+29,473
| +28% | +$1.51M | 0.01% | 1522 |
|
|
2020
Q1 | $4.78M | Sell |
104,623
-64,234
| -38% | -$2.91M | 0.01% | 1500 |
|
|
2019
Q4 | $7.3M | Sell |
168,857
-3,235
| -2% | -$132K | 0.01% | 1437 |
|
|
2019
Q3 | $6.23M | Buy |
172,092
+90,958
| +112% | +$3.83M | 0.01% | 1476 |
|
|
2019
Q2 | $3.81M | Buy |
81,134
+40,580
| +100% | +$1.72M | ﹤0.01% | 1789 |
|
|
2019
Q1 | $1.43M | Buy |
40,554
+12,797
| +46% | +$503K | ﹤0.01% | 2382 |
|
|
2018
Q4 | $1.04M | Buy |
+27,757
| New | +$1.08M | ﹤0.01% | 2630 |
|
|
2018
Q3 | – | Sell |
-15,032
| Closed | -$375K | – | 3709 |
|
|
2018
Q2 | $375K | Buy |
+15,032
| New | +$419K | ﹤0.01% | 3270 |
|
Other funds holding ATEX
OCAM
HCL
JT
PM
GI
David Shaw's ATEX Position: Q2 2026 in Review
David Shaw increased its Anterix (ATEX) stake by 1,533% in Q2 2026, buying an estimated $5.12M and bringing the position to 92,990 shares worth $9.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1847.
David Shaw first reported a position in ATEX in Q2 2018 and has held it in 32 quarters since. The position peaked at $10.4M in Q3 2024. 171 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.
- David Shaw held 92,990 shares of Anterix worth $9.57M as of Q2 2026.
- David Shaw bought 87,294 Anterix shares in Q2 2026, an estimated $5.12M.
- Anterix made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #1847 holding.
- David Shaw first reported a position in Anterix in Q2 2018 and has held it in 32 quarters since.
- David Shaw's Anterix position peaked at $10.4M in Q3 2024.
- 171 funds tracked by Wall St. Rank held Anterix as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.